FDA Import Refusal 799-2848963-8/10003/1 — Abbvie Corporation
The FDA refused shipment 799-2848963-8/10003/1 from Abbvie Corporation (Canada) on Feb 26, 2026. The refused product falls under Drugs and Biologics — ADALIMUMAB. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Feb 26, 2026
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 58SCP14 ADALIMUMAB
- Charges
- 75